Physician
Cardiovascular Associates of the Delaware Valley,p a
Cardiovascular Associates of the Delaware Valley,p a was paid $3.77M by Medicaid between Jan 2018 and Dec 2024, across 40 billing codes. Its largest line is 93010, Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only — 21% of everything it billed.
33Billing provider infoCARDIOVASCULAR ASSOCIATES OF THE DELAWARE VALLEY,P A
HADDON HEIGHTS, NJ 08035
HADDON HEIGHTS, NJ 08035
33aNPI1366495632assigned 05/18/2006
33bProvider typeCardiovascular Disease Physician
28Total paid$3.77M
24GClaims291,643
24DCodes billed40
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Cardiovascular Disease Physician providers in New Jersey
Rank by total paid#4 of 204
Median peer was paid$12K
This provider vs. median303×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 18,186 | $263K | |
| 2019 | 31,756 | $426K | |
| 2020 | 36,854 | $495K | |
| 2021 | 51,256 | $735K | |
| 2022 | 55,613 | $768K | |
| 2023 | 56,305 | $631K | |
| 2024incomplete | 41,673 | $451K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 21% | 161,700 | 147,537 | $782K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 20% | 17,666 | 17,318 | $758K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 18% | 20,096 | 19,529 | $663K |
| 93000 | 13% | 36,169 | 35,159 | $478K | |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 9.1% | 20,769 | 13,666 | $343K |
| 99254 | 3.1% | 1,170 | 1,112 | $116K | |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | 2.1% | 6,073 | 5,708 | $80K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 1.6% | 381 | 371 | $61K |
| 93298 | 1.6% | 6,074 | 5,827 | $60K | |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 1.4% | 1,445 | 1,412 | $53K |
| 93295 | 1.0% | 1,762 | 1,657 | $39K | |
| 93296 | 1.0% | 3,670 | 3,484 | $39K |
28 more codes
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 1,261 | $37K |
| 93018 | <1% | 1,429 | $37K | |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | <1% | 277 | $36K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 507 | $28K |
| 93299 | <1% | 1,325 | $24K | |
| J2785 | Injection, regadenoson, 0.1 mg | <1% | 229 | $23K |
| 93017 | <1% | 1,170 | $23K | |
| 93297 | <1% | 2,476 | $17K | |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 130 | $14K |
| 93016 | <1% | 1,453 | $12K | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 729 | $9K |
| 93294 | <1% | 1,205 | $9K | |
| 93458 | <1% | 55 | $5K | |
| 93280 | <1% | 318 | $4K | |
| 99223 | Prolong inpt eval add15 m | <1% | 128 | $3K |
| 99255 | <1% | 25 | $3K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 68 | $3K |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 134 | $2K |
| 99152 | <1% | 164 | $2K | |
| 99205 | Prolong outpt/office vis | <1% | 14 | $1K |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 1,427 | $937.75 |
| 93283 | <1% | 12 | $487.71 | |
| 99219 | <1% | 15 | $334.46 | |
| 93285 | <1% | 12 | $178.51 | |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | <1% | 31 | $170.00 |
| 99406 | <1% | 27 | $151.80 | |
| 93282 | <1% | 15 | $148.59 | |
| 78431 | 0% | 32 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDAWSON, KIM (DIRECTOR OF BUSINESS OFFICE)